ClearPoint Neuro, Inc. has grown revenue 25% a year over three years and 24% a year over five. Revenue growth, 3-year annual rate: +25% (Medical Devices median +12%). Revenue growth, 5-year rate: +24%, growth has picked up over the last three years. Years of annual history on file: 16, FY2010 to FY2025, as filed.

CLPTClearPoint Neuro, Inc.

Healthcare

$10.48-60% 1Y

$10.48

$8.6652 weeks$29.60

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +26% year on year, but operating margin narrowing (−5.2 points).

1 good, 1 to watch, 1 without data

Revenue trend+26% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +24% a year.

Margin direction−5.2 points operating

Trailing-twelve-month operating margin, -72.8% now against -67.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CLPT growing?

ClearPoint Neuro, Inc. has grown revenue 25% a year over three years and 24% a year over five.

+25%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +24%
Revenue growth, 5-year rate · +25% over three · growth has picked up over the last three years
Years of annual history on file: 16
Years of annual history on file · FY2010 to FY2025, as filed

Details›